C. Suppli Ulrik (Hvidovre, Denmark), D. Mannino (Lexington, United States of America), P. Burney (London, United Kingdom)
LATE-BREAKING ABSTRACT: Clinical profile of adult patients with invasive pneumococcal disease (IPD) during a 3 year surveillance in Belgium
W. De Backer, J. Verhaegen, J. Flamaing, W. E. Peetermans, P. Van Damme, B. Delaere, Y. Van Laethem, A. Mignon, F. Surmont (Antwerp, Leuven, , Yvoir, Brussels, Belgium)
|   |
Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway
M. Waatevik, T. Skorge, E. Omenaas, P. Bakke, A. Gulsvik, A. Johannessen (Bergen, Norway)
| |
Prevalence of respiratory symptoms and airflow limitation in a nationally representative random sample in England
M. Kearney, J. Mindell, R. Craig, J. Clarke, A. Moger, K. Holton, R. Winter, S. Hill (London, , Cambridge, United Kingdom)
| |
Prevalence of COPD in Algerian military
K. Salah (Constantine, Algeria)
| |
A detached island residents‘ smoking habits and their prevalence of COPD
Y. Yanagita, K. Oue, T. Tanaka, H. Senjyu (Nagasaki, Japan)
| |
Distribution of COPD patients in the GOLD assessment framework by exacerbations
G. Nadeau, L. Adamek, M. Small (Uxbridge, Macclesfield, United Kingdom)
| |
Chronic bronchitis phenotype in subjects with and without COPD: The PLATINO study
M. Montes de Oca, R.J. Halbert, M.V. Lopez, R. Perez-Padilla, C. Tálamo, D. Moreno, A. Muiño, J.R. Jardim, G. Valdivia, J. Pertuzé, A.M.B. Menezes (Caracas, Venezuela; Los Angeles, United States Of America; Montevideo, Uruguay; Mexico City, Mexico; Pelotas, Brazil; Santiago de Chile, Chile)
| |
Prevalence characteristics of COPD in never smokers
R. Bakr, I. Elmahallawy (Shebin Elkom, Egypt)
| |
Profiling dyspnoea in primary care patients with COPD
H. Mullerova, C. Lu, M. Tabberer (Uxbridge, United Kingdom; Research Triangle Park, United States Of America)
| |
The relation between prevalence of chronic respiratory symptoms and ventilatory dysfunctions – A crossectional study in a industrial area from Constanta Harbor
C. Didilescu, G. Apti, A. Trailescu, H. Memis (Bucharest, Constanta, Romania)
| |
Influence of gender and age on correlation between body mass index and lung function in COPD
I. Filipovic, L. Isakovic, J. Isakovic (Sokobanja, Belgrade, Republic Of Serbia)
| |
Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
P. Pavlov, Y. Ivanov, P. Glogovska, T. Popova, E. Borisova, V. Nozharov (Pleven, Bulgaria)
| |
Prevalence of comorbidities in subjects with airflow obstruction in Japan
H. Omori, A. Onoue, Y. Shinonome, N. Higashi, W. Miyazaki, Y. Ogata, T. Tsuda, H. Kohrogi, T. Katoh (Kumamoto, Kitakyushu, Japan)
| |
Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework
P.W. Jones, G. Nadeau, M. Small, L. Adamek (London, Uxbridge, Macclesfield, United Kingdom)
| |
Association of COPD stages and comorbidities in Italian general practices: The COMODHES study
S. Maio, S. Baldacci, M. Borbotti, F. Martini, P. Silvi, G. Sarno, S. Cerrai, A. Pala, G. Viegi (Pisa, Palermo, Italy)
| |
COPD and comorbidity in somatic practice
A. Vertkin, A. Skotnikov, M. Rumyantsev (Moscow, Russian Federation)
| |
Disease severity and complexity in patients with acute exacerbation of chronic obstructive pulmonary disease in Lazio, Italy
U. Kirchmayer, N. Agabiti, M. Di Martino, L. Bauleo, L. Pinnarelli, D. Fusco, R. Pistelli, V. Colamesta, M. Davoli (Rome, Italy)
| |
Characteristics of COPD exacerbations in Greece
F. Malli, Z. Daniil, E. Bania, E.C. Alexopoulos, N. Tzanakis, E. Kosmas, M. Toumbis, K.I. Goyrgoulianis (Larissa, Athens, Heraklion, Greece)
| |
Mortality risks of COPD for nonsmokers and smokers from a prospective cohort study of 390,269 subjects in Taiwan – Assessing involvement beyond the lungs
W.E. Cheng, C.P. Wen, M.K. Tsai, Y.C. Yang, X. Wu (Taichung, Zhunan, Taiwan; Houston, United States Of America)
| |
Insufficient education about COPD is main factor for low diagnosis rate
F. Mihaltan, R. Nemes, A. Ionescu (Bucharest, Romania)
| |